Powered by a top-ranked research program, the University of Wisconsin–Madison, its affiliate organizations and the startup companies coming out of the university have a total $30.8 billion annual statewide economic…
Crossroads of Ideas revisits the health of our democracy
UW experts weigh in with the latest status check at February 18 talk CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – Our country…
Beyond fun: Discovery Outreach strengthening bond between science, society
Laura Heisler and her Discovery Outreach team are growing an iceberg. The visible part of that iceberg can be seen on a regular basis in the Discovery Building, through programs…
UW–Madison initiative to promote university-industry research and education partnerships
The Office of the Vice Chancellor for Research and Graduate Education has launched a new funding effort to facilitate university research partnerships and graduate student internships in collaboration with the…
New potential drug to test fibrosis
Kidney disease. Heart failure. Diabetes. COVID-19. In all these conditions and more, the body’s normal healing process can run amok, leading to fibrosis, an excessive accumulation of connective tissue in…
Submissions invited for WARF Accelerator Microbiome Challenge Grant
WARF will award 2-5 grants from a $100K pool CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – The Wisconsin Alumni Research Foundation has…
Positive and negative
Introducing Geladen, a young startup launched by former UW–Madison professor (and WARF Accelerator alum) Mark Etzel. The company is advancing a pair of ultra-charged technologies that could transform dairy processing…
Specialized COVID-19 face shield protects surgeons in the operating room
The Surgical Shield Design is available for commercial licensing through the University of Wisconsin-Madison’s technology transfer partner, Wisconsin Alumni Research Foundation (WARF). WARF is providing a time-limited royalty free license to companies…